NGF and osteoarthritis: The therapeutic concept of blocking the activity of NGF for chronic and inflammatory pain received a very strong validation from the results of proof-of concept clinical trials showing that tanezumab can very effectively and persistently relieve joint pain and improve functions in moderate-to-severe osteoarthritis patients [75].